Juhasz I et al. Development of pemphigus vulgaris-like lesions in severe combined immunodeficiency disease mice reconstituted with lymphocytes from patients. (1993) JOURNAL OF CLINICAL INVESTIGATION 0021-9738 1558-8238 92 5 2401-2407,
2424254
Szakcikk (Folyóiratcikk) | Tudományos[2424254]
Gilet Jules et al. Role of CCL17 in the Generation of Cutaneous Inflammatory Reactions in Hu-PBMC-SCID Mice Grafted with Human Skin. (2009) JOURNAL OF INVESTIGATIVE DERMATOLOGY 0022-202X 1523-1747 129 4 879-890
Zhang Baojun et al. Mouse models with human immunity and their application in biomedical research. (2009) JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 1582-1838 1582-4934 13 6 1043-1058
King Marie et al. Humanized Mice for the Study of Type 1 Diabetes and Beta Cell Function. (2008) ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 0077-8923 1749-6632 1150 46-53
Aisa Y et al. Cicatricial pemphigoid of the oropharynx after allogeneic stem cell transplantation for relapsed follicular lymphoma. (2005) INTERNATIONAL JOURNAL OF HEMATOLOGY 0925-5710 1865-3774 82 3 266-269
Kurtz A et al. Differential regulation of a fibroblast growth factor-binding protein during skin carcinogenesis and wound healing. (2004) NEOPLASIA 1522-8002 1476-5586 6 5 595-602
Tsicopoulos A et al. Chemokines in cutaneous allergic reactions: the SCID model as a powerful tool to evaluate their interest as therapeutical targets. (2003) REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE 0335-7457 1768-3149 43 4 206-210
Radisch T et al. The humanized SCID mouse model to study HLA class II-linked autoimmunity to desmoglein 3 in pemphigus vulgaris. (2002) BRITISH JOURNAL OF DERMATOLOGY 0007-0963 1365-2133 146 2 189-193
Ohyama M et al. Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris. (2002) JOURNAL OF INVESTIGATIVE DERMATOLOGY 0022-202X 1523-1747 118 1 199-204
Senechal S et al. CCR3-blocking antibody inhibits allergen-induced eosinophil recruitment in human skin xenografts from allergic patients. (2002) LABORATORY INVESTIGATION 0023-6837 1530-0307 82 7 929-939
Salopek TG et al. Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder. (2002) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 0190-9622 1097-6787 47 5 785-788
Hertl M et al. Autoreactive T cells as potential targets for immunotherapy of autoimmune bullous skin diseases. (2001) CLINICS IN DERMATOLOGY 0738-081X 1879-1131 19 5 592-597
Amagai M et al. Use of autoantigen-knockout mice in developing an active disease model for pemphigus. (2000) JOURNAL OF CLINICAL INVESTIGATION 0021-9738 1558-8238 105 5 625-631
Hertl M. Humoral and cellular autoimmunity in autoimmune bullous skin disorders. (2000) INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY 1018-2438 1423-0097 122 2 91-100
Boehncke WH. The SCID-hu xenogeneic transplantation model: complex but telling. (1999) ARCHIVES OF DERMATOLOGICAL RESEARCH 0340-3696 1432-069X 291 7-8 367-373
Fan JL et al. BALB/c mice produce blister-causing antibodies upon immunization with a recombinant human desmoglein 3. (1999) JOURNAL OF IMMUNOLOGY 0022-1767 1550-6606 163 11 6228-6235
Tsicopoulos A et al. Tuberculin-induced delayed-type hypersensitivity reaction in a model of hu-PBMC-SCID mice grafted with autologous skin. (1998) AMERICAN JOURNAL OF PATHOLOGY 0002-9440 1525-2191 152 6 1681-1688
Roye O et al. Dermal endothelial cells and keratinocytes produce IL-7 in vivo after human Schistosoma mansoni percutaneous infection. (1998) JOURNAL OF IMMUNOLOGY 0022-1767 1550-6606 161 8 4161-4168
Montagutelli X et al. Vesicle formation and follicular root sheath separation in mice homozygous for deleterious alleles at the balding (bal) locus. (1997) JOURNAL OF INVESTIGATIVE DERMATOLOGY 0022-202X 1523-1747 109 3 324-328
Memar OM et al. Recombinant desmoglein 3 has the necessary epitopes to adsorb and induce blister-causing antibodies. (1996) JOURNAL OF INVESTIGATIVE DERMATOLOGY 0022-202X 1523-1747 106 2 261-268
Sundberg JP et al. Mouse mutations as animal models and biomedical tools for dermatological research. (1996) JOURNAL OF INVESTIGATIVE DERMATOLOGY 0022-202X 1523-1747 106 2 368-376
Hayashi Y et al. Animal model of focal tonsillar infection: Human tonsillar lymphocytes induce skin lesion in SCID mice. (1996) ACTA OTO-LARYNGOLOGICA 0001-6489 1651-2251 193-196
RAJASENAN RS et al. EXPRESSION AND INDUCIBILITY OF ANTIGENS IN SEVERE COMBINED IMMUNODEFICIENT MICE RECOGNIZED BY HUMAN ANTI-P450 ANTIBODIES. (1995) TOXICOLOGY AND APPLIED PHARMACOLOGY 0041-008X 1096-0333 135 1 89-99
VLADUTIU AO. CAN AUTOIMMUNE-DISEASES BE INDUCED IN SEVERE COMBINED IMMUNODEFICIENT (SCID) MICE. (1994) RESEARCH IN IMMUNOLOGY 0923-2494 1879-1425 145 5 363-370
Juhasz I et al. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. (1993) AMERICAN JOURNAL OF PATHOLOGY 0002-9440 1525-2191 143 2 528-537,
2188640
Szakcikk (Folyóiratcikk) | Tudományos[2188640]
Sroda-Pomianek Kamila et al. Pretreatment of Melanoma Cells with Aqueous Ethanol Extract from Madhuca longifolia Bark Strongly Potentiates the Activity of a Low Dose of Dacarbazine. (2024) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 25 13
Ju Robert J. et al. Compression-dependent microtubule reinforcement enables cells to navigate confined environments. (2024) NATURE CELL BIOLOGY 1465-7392 1476-4679
Shoji Kenji F. et al. The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential. (2023) EMBO REPORTS 1469-221X 1469-3178 24 4
Surman Magdalena et al. Similarities and Differences in the Protein Composition of Cutaneous Melanoma Cells and Their Exosomes Identified by Mass Spectrometry. (2023) CANCERS 2072-6694 15 4
Sittewelle Meghane et al. PFKFB4 interacts with ICMT and activates RAS/AKT signaling-dependent cell migration in melanoma. (2022) LIFE SCIENCE ALLIANCE 2575-1077 5 12
Fischer Robert S. et al. Contractility, focal adhesion orientation, and stress fiber orientation drive cancer cell polarity and migration along wavy ECM substrates. (2021) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 0027-8424 1091-6490 118 22
Palko-Labuz Anna et al. Conjugation with Phospholipids as a Modification Increasing Anticancer Activity of Phenolic Acids in Metastatic Melanoma-In Vitro and In Silico Studies. (2021) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 22 16
Surman Magdalena et al. Mass Spectrometry-Based Proteomic Characterization of Cutaneous Melanoma Ectosomes Reveals the Presence of Cancer-Related Molecules. (2020) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 21 8
Hanniford Douglas et al. Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis. (2020) CANCER CELL 1535-6108 1878-3686 37 1 55-+
Kosnopfel Corinna et al. YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT. (2018) MOLECULAR CANCER RESEARCH 1541-7786 1557-3125 16 7 1149-1160
Hejna Miroslav et al. Quantification of mammalian tumor cell state plasticity with digital holographic cytometry. (2018) Megjelent: Quantitative Phase Imaging IV
Surman Magdalena et al. Human melanoma-derived ectosomes are enriched with specific glycan epitopes. (2018) LIFE SCIENCES 0024-3205 1879-0631 207 395-411
Wasinger Christine et al. Amino Acid Signature in Human Melanoma Cell Lines from Different Disease Stages. (2018) SCIENTIFIC REPORTS 2045-2322 2045-2322 8
Massari Noelia A et al. Histamine therapeutic efficacy in metastatic melanoma: Role of histamine H-4 receptor agonists and opportunity for combination with radiation. (2017) ONCOTARGET 1949-2553 8 16 26471-26491
Ivanov VN et al. Regulation of viability, differentiation and death of human melanoma cells carrying neural stem cell biomarkers: a possibility for neural trans-differentiation. (2015) APOPTOSIS 1360-8185 1573-675X 20 7 996-1015
Peretz Y et al. Inhibitor of DNA Binding 4 (ID4) Is Highly Expressed in Human Melanoma Tissues and May Function to Restrict Normal Differentiation of Melanoma Cells. (2015) PLOS ONE 1932-6203 1932-6203 10 2
Gendreau Isabelle et al. Pigmented Skin Models: Understand the Mechanisms of Melanocytes. (2013) Megjelent: REGENERATIVE MEDICINE AND TISSUE ENGINEERING pp. 759-785
Hylander BL et al. Origin of the vasculature supporting growth of primary patient tumor xenografts. (2013) JOURNAL OF TRANSLATIONAL MEDICINE 1479-5876 1479-5876 11
Lian CG et al. Diagnostic implications of loss of 5-hydroxymethylcytosine for melanoma. (2013) EXPERT REVIEW OF DERMATOLOGY 1746-9872 1746-9880 8 2 99-101
Pierzchala Katarzyna et al. Photocatalytic and phototoxic properties of TiO2-based nanofilaments: ESR and AFM assays. (2012) NANOTOXICOLOGY 1743-5390 1743-5404 6 8 813-824
Kiowski Gregor et al. Engineering Melanoma Progression in a Humanized Environment In Vivo. (2012) JOURNAL OF INVESTIGATIVE DERMATOLOGY 0022-202X 1523-1747 132 1 144-153
Phipps Laura E et al. Targeting Cell Spreading: A Method of Sensitizing Metastatic Tumor Cells to TRAIL-Induced Apoptosis. (2011) MOLECULAR CANCER RESEARCH 1541-7786 1557-3125 9 3 249-258
Schittek Birgit et al. Melanoma Model Systems. (2011) Megjelent: MELANOMA DEVELOPMENT: MOLECULAR BIOLOGY, GENETICS AND CLINICAL APPLICATION pp. 309-335
Gremel G et al. Functional and prognostic relevance of the homeobox protein MSX2 in malignant melanoma. (2011) BRITISH JOURNAL OF CANCER 0007-0920 1532-1827 105 4 565-574
Frank Natasha Y et al. The therapeutic promise of the cancer stem cell concept. (2010) JOURNAL OF CLINICAL INVESTIGATION 0021-9738 1558-8238 120 1 41-50
Wang Huan et al. Comparison of Extensive Protein Fractionation and Repetitive LC-MS/MS Analyses on Depth of Analysis for Complex Proteomes. (2010) JOURNAL OF PROTEOME RESEARCH 1535-3893 1535-3907 9 2 1032-1040
Gremel Gabriela et al. Identification and functional validation of therapeutic targets for malignant melanoma. (2009) CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 1040-8428 1879-0461 72 3 194-214
Di Qin et al. The biology of Kaposis sarcoma-associated herpesvirus and the infection of human immunodeficiency virus. (2008) VIROLOGICA SINICA 1674-0769 1995-820X 23 6 473-485
Yonou H et al. Histopathologic study of osteoblastic metastasis in prostate cancer and inhibition of osteoclastic bone resorption for the treatment of prostate cancer: Relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions. (2007) Nishinihon Journal of Urology 0029-0726 69 4 209-220
Topczewska Jolanta M et al. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. (2006) NATURE MEDICINE 1078-8956 1546-170X 12 8 925-932
Gallagher WM et al. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies. (2005) CARCINOGENESIS 0143-3334 1460-2180 26 11 1856-1867
Schmieder AH et al. Molecular MR imaging of melanoma angiogenesis with alpha(nu)beta(3)-targeted paramagnetic nanoparticles. (2005) MAGNETIC RESONANCE IN MEDICINE 0740-3194 1522-2594 53 3 621-627
Volkel T et al. Targeting of immunoliposomes to endothelial cells using a single-chain Fv fragment directed against human endoglin (CD105). (2004) BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 0005-2736 1879-2642 1663 1-2 158-166
Kurtz A et al. Differential regulation of a fibroblast growth factor-binding protein during skin carcinogenesis and wound healing. (2004) NEOPLASIA 1522-8002 1476-5586 6 5 595-602
Tahtis K et al. Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model. (2003) MOLECULAR CANCER THERAPEUTICS 1535-7163 1538-8514 2 8 729-737
Samaniego F et al. Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts. (2002) CELL GROWTH AND DIFFERENTIATION 1044-9523 2377-0732 1541-7786 13 8 387-395
Aho S et al. Specific sequences in p120ctn determine subcellular distribution of its multiple isoforms involved in cellular adhesion of normal and malignant epithelial cells. (2002) JOURNAL OF CELL SCIENCE 0021-9533 1477-9137 115 7 1391-1402
Bankert RB et al. SCID mouse models to study human cancer pathogenesis and approaches to therapy: Potential, limitations, and future directions. (2002) FRONTIERS IN BIOSCIENCE 1093-9946 1093-4715 7 C44-C62
Yonou H et al. Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. (2001) CANCER RESEARCH 0008-5472 1538-7445 61 5 2177-2182
Takahashi N et al. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide. (2001) CANCER RESEARCH 0008-5472 1538-7445 61 21 7846-7854
Nemeth JA et al. Persistence of human vascular endothelium in experimental human prostate cancer bone tumors. (2000) CLINICAL & EXPERIMENTAL METASTASIS 0262-0898 1573-7276 18 3 231-237
Bechetoille N et al. Penetration of human metastatic melanoma cells through an authentic dermal-epidermal junction is associated with dissolution of native collagen types IV and VII. (2000) MELANOMA RESEARCH 0960-8931 1473-5636 10 5 427-434
Antunes L et al. Analysis of tissue chimerism in nude mouse brain and abdominal xenograft models of human glioblastoma multiforme: What does it tell us about the models and about glioblastoma biology and therapy?. (2000) JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY 0022-1554 1551-5044 48 6 847-858
Zendman AJW et al. TM7XN1, a novel human EGF-TM7-like cDNA, detected with mRNA differential display using human melanoma cell lines with different metastatic potential. (1999) FEBS LETTERS 0014-5793 1873-3468 446 2-3 292-298
DeLisser HM et al. Loss of endothelial surface expression of E-selectin in a patient with recurrent infections. (1999) BLOOD 0006-4971 1528-0020 94 3 884-894
Zhu ZP et al. Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody. (1999) CANCER LETTERS 0304-3835 1872-7980 136 2 203-213
Zhu ZP et al. Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor. (1999) INVESTIGATIONAL NEW DRUGS 0167-6997 1573-0646 17 3 195-212
Witte L et al. Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy. (1998) CANCER AND METASTASIS REVIEWS 0167-7659 1573-7233 17 2 155-161
Randazzo BP et al. Treatment of experimental subcutaneous human melanoma with a replication-restricted herpes simplex virus mutant. (1997) JOURNAL OF INVESTIGATIVE DERMATOLOGY 0022-202X 1523-1747 108 6 933-937
Takizawa Y et al. New immunodeficient (nude-scid, beige-scid) mice as excellent recipients of human skin grafts containing intraepidermal neoplasms. (1997) ARCHIVES OF DERMATOLOGICAL RESEARCH 0340-3696 1432-069X 289 4 213-218
Freije Jmp et al. Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines. (1997) NATURE MEDICINE 1078-8956 1546-170X 3 395-401
Bullard KM et al. Human acellular dermal matrix as a novel model of malignant epithelial cell invasion. (1997) INVASION & METASTASIS 0251-1789 1423-0119 17 1 42-52
Schadendorf D et al. Metastatic potential of human melanoma cells in nude mice - Characterisation of phenotype, cytokine secretion and tumour-associated antigens. (1996) BRITISH JOURNAL OF CANCER 0007-0920 1532-1827 74 2 194-199
Petzelbauer P et al. Human delayed-type hypersensitivity reaction in a SCID mouse engrafted with human T cells and autologous skin. (1996) JOURNAL OF INVESTIGATIVE DERMATOLOGY 0022-202X 1523-1747 107 4 576-581
